{'output': [['Eiger BioPharmaceuticals Inc', 'COMP', 'Stop', 'Development of its drug', 'PRODUCT'], ['Drug', 'PRODUCT', 'Fail', 'Mid-stage study', 'EVENT'], ['Drug', 'PRODUCT', 'Fail', 'Improving pulmonary vascular resistance', 'CONCEPT'], ['Company', 'ORG', 'Continue', 'Testing the drug for lymphedema', 'CONCEPT'], ['Company', 'ORG', 'Expect', 'Data for a mid-stage trial in lymphedema', 'EVENT'], ['Company', 'ORG', 'Shares Slump', 'About 39 percent to $9.7', 'ECON_INDICATOR']]}